您的位置: 首页 > 农业专利 > 详情页

专利权人:
ENVISIA THERAPEUTICS INC.
发明人:
Benjamin MAYNOR,Andres GARCIA,Sanjib Kumar DAS,Tomas NAVRATIL,Benjamin Robinson YERXA,Janet TULLY
申请号:
MX2016007345
公开号:
MX2016007345A
申请日:
2014.12.05
申请国别(地区):
MX
年份:
2016
代理人:
摘要:
The disclosure teaches precisely engineered biodegradable drug delivery systems and methods of making and utilizing such systems. In aspects, the biodegradable drug delivery systems taught herein comprise ocular implants having a desired extended drug release profile suitable for treating elevated intraocular pressure. The disclosure teaches precisely engineered biodegradable drug delivery systems and methods of making and utilizing such systems. In aspects, the biodegradable drug delivery systems taught herein comprise ocular implants having a desired extended drug release profile suitable for treating elevated intraocular pressure. Systems and methods are disclosed for providing memory address translation for a memory management system. One embodiment of such a system comprises a memory device and an application processor in communication via a system interconnect. The application processor comprises test code for testing one or more of a plurality of hardware devices. Each of the hardware devices has a corresponding system memory management unit (SMMU) for processing memory requests associated with the hardware device to the memory device. The system further comprises a client-side address translation system in communication with the system interconnect and the plurality of SMMUs. The client-side address translation system is configured to selectively route stimulus traffic associated with the test code to a client port on one or more of the plurality of SMMUs for testing the corresponding hardware devices.La divulgación provee sistemas de administración de fármacos biodegradables modificados en forma precisa y métodos para elaborar y utilizar dichos sistemas. En aspectos, los sistemas de administración de fármaco biodegradables provistos en la presente documentación comprenden implantes oculares que tienen un perfil extendido de liberación de fármaco deseado adecuado para tratar la presión intraocular elevada.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充